Introduction:Basic information about CAS 159138-80-4|Cariporide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Cariporide |
|---|
| CAS Number | 159138-80-4 | Molecular Weight | 283.347 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 542.8±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C12H17N3O3S | Melting Point | / |
|---|
| MSDS | ChineseUSA | Flash Point | 282.1±32.9 °C |
|---|
Names
| Name | N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide |
|---|
| Synonym | More Synonyms |
|---|
Cariporide BiologicalActivity
| Description | Cariporide (HOE-642) is a selective Na+/H+ exchange inhibitor. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>Sodium ChannelResearch Areas >>Cardiovascular DiseaseResearch Areas >>Inflammation/Immunology |
|---|
| In Vitro | Cariporide significantly suppresses markers of cell death, such as TUNEL positivity and caspase-3 cleavage, at 8 or 16 hours. Cariporide remarkably suppresses cytosolic Na+ and Ca2+ accumulation. Cariporide prevents mitochondrial membrane potential loss induced by H2+O2+[1]. Cariporide (HOE-642) ameliorates myocardial ischemia/reperfusion injury, by the well-established reduction of cytosolic Ca2+ in cardiac myocytes through inhibition of Na+/H+ exchange[2]. Cariporide (HOE-642), has inhibitory effects on the degranulation of human platelets, the formation of platelet–leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1)[3]. |
|---|
| In Vivo | Intravenous administration of cariporide significantly decreases brain Na+ uptake and reduces cerebral edema, brain swelling, and infarct volume[4]. |
|---|
| Cell Assay | Neonatal rat cardiomyocytes are randomly separated into groups: (1) control group, (2) incubation with 100 μM hydrogen peroxide, or (3) pretreatment with 10 μM cariporide for 20 minutes followed by 100 μM hydrogen peroxide. Caspase-3 activity is measured by detection of the cleavage of a colorimetric caspase-3 substrate, N-acetyl-Asp-Glu-Val-Asp-p-nitroaniline, using an assay kit[1]. |
|---|
| Animal Admin | Rats: Cariporide and/or bumetanide are administered intravenously (15 or 30 mg/kg in 2 to 4 doses, respectively, of 7.5 mg/kg) starting at 20 minutes before initiation of pMCAO. For neurologic outcome experiments, some rats are given cariporide and/or bumetanide by a single intraperitoneal injection[4]. |
|---|
| References | [1]. Teshima Y, et al. Cariporide (HOE642), a selective Na+-H+ exchange inhibitor, inhibits the mitochondrial death pathway. Circulation. 2003 Nov 4;108(18):2275-81. [2]. Chang HB, et al. Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide. Exp Neurol. 2015 Oct;272:11-6. [3]. O'Donnell ME, et al. Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger. J Cereb Blood Flow Metab. 2013 Feb;33(2):225-34. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 542.8±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C12H17N3O3S |
|---|
| Molecular Weight | 283.347 |
|---|
| Flash Point | 282.1±32.9 °C |
|---|
| Exact Mass | 283.099060 |
|---|
| PSA | 123.99000 |
|---|
| LogP | 0.40 |
|---|
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
|---|
| Index of Refraction | 1.602 |
|---|
| InChIKey | IWXNYAIICFKCTM-UHFFFAOYSA-N |
|---|
| SMILES | CC(C)c1ccc(C(=O)N=C(N)N)cc1S(C)(=O)=O |
|---|
| Storage condition | 2-8℃ |
|---|
Safety Information
| RIDADR | NONH for all modes of transport |
|---|
| RTECS | CV2310560 |
|---|
Synonyms
| HOE642 |
| Cariporide |
| N-(Diaminomethylene)-4-isopropyl-3-(methylsulfonyl)benzamide |
| Benzamide, N-(diaminomethylene)-4-(1-methylethyl)-3-(methylsulfonyl)- |
| N-Carbamimidoyl-4-isopropyl-3-(methylsulfonyl)benzamide |
| benzamide, N-(aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)- |
| N-(diaminomethylidene)-3-(methylsulfonyl)-4-(propan-2-yl)benzamide |